335 related articles for article (PubMed ID: 30946047)
1. Sildenafil for Pulmonary Arterial Hypertension.
Bhogal S; Khraisha O; Al Madani M; Treece J; Baumrucker SJ; Paul TK
Am J Ther; 2019; 26(4):e520-e526. PubMed ID: 30946047
[TBL] [Abstract][Full Text] [Related]
2. A focus on riociguat in the treatment of pulmonary arterial hypertension.
Toxvig AK; Wehland M; Grimm D; Infanger M; Krüger M
Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):202-214. PubMed ID: 31206240
[TBL] [Abstract][Full Text] [Related]
3. Modulating NO-GC Pathway in Pulmonary Arterial Hypertension.
D'Agostino A; Lanzafame LG; Buono L; Crisci G; D'Assante R; Leone I; De Vito L; Bossone E; Cittadini A; Marra AM
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203205
[TBL] [Abstract][Full Text] [Related]
4.
Peng Y; Dai J; Zhao YY
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768713
[TBL] [Abstract][Full Text] [Related]
5. [Phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension].
Beltrán-Gámez ME; Sandoval-Zárate J; Pulido T
Arch Cardiol Mex; 2015; 85(3):215-24. PubMed ID: 26047999
[TBL] [Abstract][Full Text] [Related]
6. Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension.
Hoeper MM; Ewert R; Jansa P; Sirenko Y; Skride A; Balagtas C; Hackley S; Vogt S; Abreu P; Haughie S; Hassan T; Oudiz RJ
Circulation; 2024 Jun; 149(25):1949-1959. PubMed ID: 38752352
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in a Patient with β-Thalassemia Major and Severe Pulmonary Arterial Hypertension.
Pinto VM; Derchi GE; Bacigalupo L; Pontali E; Forni GL
Hemoglobin; 2020 May; 44(3):218-220. PubMed ID: 32552139
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
Kido K; Coons JC
Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
[TBL] [Abstract][Full Text] [Related]
9. Advances in targeted therapy for pulmonary arterial hypertension in children.
Li L; Zhu X; Chen X; Gao J; Ding C; Zhang M; Ma S
Eur J Pediatr; 2023 May; 182(5):2067-2076. PubMed ID: 36527480
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
Mandras S; Kovacs G; Olschewski H; Broderick M; Nelsen A; Shen E; Champion H
J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):453-462. PubMed ID: 33836637
[TBL] [Abstract][Full Text] [Related]
11. Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment.
Grünig E; Ohnesorge J; Benjamin N; Burhenne J; Enderle Y; Egenlauf B; Fischer C; Harutyunova S; Huppertz A; Klose H; Haefeli WE
Respiration; 2017; 94(1):26-37. PubMed ID: 28494463
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications.
Ala M; Mohammad Jafari R; Dehpour AR
Fundam Clin Pharmacol; 2021 Apr; 35(2):235-259. PubMed ID: 33226665
[TBL] [Abstract][Full Text] [Related]
13. Effect of Sildenafil Citrate on Pulmonary Arterial Systolic Pressure and Sub-maximal Exercise Capacity in Chronic Obstructive Pulmonary Disease.
Shrestha SK; Srivastava B; Karki M; Khatri DB; Pradhan RM
Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):271-278. PubMed ID: 30580340
[TBL] [Abstract][Full Text] [Related]
14. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
[TBL] [Abstract][Full Text] [Related]
15. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
[TBL] [Abstract][Full Text] [Related]
16. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives.
Zheng W; Wang Z; Jiang X; Zhao Q; Shen J
J Med Chem; 2020 Dec; 63(24):15153-15186. PubMed ID: 33314936
[TBL] [Abstract][Full Text] [Related]
17. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
Hoendermis ES; Liu LC; Hummel YM; van der Meer P; de Boer RA; Berger RM; van Veldhuisen DJ; Voors AA
Eur Heart J; 2015 Oct; 36(38):2565-73. PubMed ID: 26188003
[TBL] [Abstract][Full Text] [Related]
18. [Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat].
Martynyuk TV; Shmalts AA; Gorbachevsky SV; Chazova IE
Ter Arkh; 2021 Sep; 93(9):1117-1124. PubMed ID: 36286873
[TBL] [Abstract][Full Text] [Related]
19. The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study.
Hidayati F; Gharini PPR; Hartopo AB; Anggrahini DW; Dinarti LK
Health Qual Life Outcomes; 2020 Aug; 18(1):278. PubMed ID: 32795300
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.
Oliynyk OV; Rorat M; Strepetova OV; Dubrov SO; Guryanov VG; Oliynyk YV; Kulivets OS; Ślifirczyk A; Barg W
Viruses; 2023 May; 15(5):. PubMed ID: 37243243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
